切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (04) : 447 -449. doi: 10.3877/cma.j.issn.1674-3946.2021.04.026

论著

两种手术方式治疗甲状腺微小乳头状癌的安全性及近期预后比较
文骝1,(), 庞士勇1, 李娟1   
  1. 1. 237000 安徽医科大学附属六安医院
  • 收稿日期:2020-09-19 出版日期:2021-08-17
  • 通信作者: 文骝

Comparison of safety and short-term clinical outcome of two surgical procedures in treating papillary thyroid microcarcinoma

Liu Wen1,(), Shiyong Pang1, Juan Li1   

  1. 1. Liu’an Hospital Affiliated to Anhui Medical University, Anhui 237000, China
  • Received:2020-09-19 Published:2021-08-17
  • Corresponding author: Liu Wen
  • Supported by:
    Scientific Research Project of Anhui Health Planning Commission(2016QK028)
引用本文:

文骝, 庞士勇, 李娟. 两种手术方式治疗甲状腺微小乳头状癌的安全性及近期预后比较[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(04): 447-449.

Liu Wen, Shiyong Pang, Juan Li. Comparison of safety and short-term clinical outcome of two surgical procedures in treating papillary thyroid microcarcinoma[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(04): 447-449.

目的

探讨患侧甲状腺联合峡部切除术合并中央区淋巴结清扫术治疗甲状腺微小乳头状癌(PTMC)的安全性和近期预后比较。

方法

回顾性分析2017年1月至2020年6月90例PTMC患者资料,根据是否进行中央区淋巴结清扫术分为两组,其中40例予以患侧甲状腺联合峡部切除术联合中央区淋巴结清扫术(清扫组),50例予以患侧甲状腺联合峡部切除术(未清扫组)。统计学分析采用SPSS 23.0软件进行比较,两组患者术中术后指标、甲状旁腺素(PTH)和血钙水平等计量资料采用(±s)表示,独立样本t检验。两组患者术后并发症发生率、复发率和转移率采用χ2检验,P<0.05为差异有统计学意义。

结果

未清扫组患者手术时间、术中出血量、切口长度、术后疼痛评分、引流管引流量、住院时间及术后并发症发生率均明显小于清扫组患者(P<0.05),未清扫组术后血清PTH和血钙水平均明显高于清扫组患者(P<0.05);两组术后2年复发率、转移率相比,差异无统计学意义(P>0.05)。

结论

患侧甲状腺联合峡部切除术治疗PTMC具有更好的治疗安全性和较低的并发症发生率,且不影响术后近期预后。

Objective

To investigate the safety and short-term clinical outcome of combined isthmic thyroidectomy with central lymph node dissection in the treatment of papillary thyroid microcarcinoma(PTMC).

Methods

A retrospective analysis of the data of 90 patients with PTMC from January 2017 to June 2020 was divided into two groups according to whether the central lymph node dissection was performed, and 40 cases underwent the ipsilateral and isthmic thyroid resection combined with the central lymph node dissection(swept group), 50 cases underwent the ipsilateral and isthmic thyroid resection without the central area lymph node dissection (unswept group). Statistical analysis were performed by using SPSS 23.0 software. Measurement data such as Intraoperative and postoperative indicators, parathyroid hormone (PTH) and serum calcium level were expressed as (±s), and were examined by using independent t test. The incidence of postoperative complications, recurrence rate and metastasis rate of the two groups were analyzed by using χ2 test, and A P value of<0.05 was considered as statistically significant difference.

Results

The operative time, intraoperative bleeding, incision length, postoperative pain score, drainage volume, hospitalization time and postoperative complication rate in the unswept group were significantly lower than those in the swept group (P<0.05) , the levels of serum PTH and serum calcium were significantly higher in the unswept group than those in the swept group (P<0.05) , with no significant difference of the recurrence and metastasis rate between two groups (P>0.05).

Conclusion

Compared with the combined central lymph node dissection, the combined isthmic thyroidectomy without central lymph node dissection in the treatment of papillary thyroid carcinoma has advantages such as more safe and lower incidence of complications, with similar short-term clinical outcome.

表1 90例PTMC不同术式两组患者一般临床资料比较[(±s),例]
表2 90例PTMC不同术式两组患者手术相关指标比较(±s)
表3 90例PTMC不同术式两组患者术后相关指标比较(±s)
表4 90例PTMC不同术式两组患者术后PTH和血钙指标比较(±s)
表5 90例PTMC不同术式两组患者术后1周不良反应事件比较[例(%)]
[1]
陈明军. 甲状腺侧叶切除术联合峡部切除术与甲状腺双侧叶全切术治疗甲状腺微小乳头状癌的效果比较[J]. 河南医学研究,2020,29(18):3341-3343.
[2]
Wang K, Xu J, Li S, et al. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma[J]. Cancer Med, 2019, 8(16): 6977-6985.
[3]
许龙国. 甲状腺单侧联合峡部切除治疗甲状腺微小乳头状癌的临床疗效[J]. 世界最新医学信息文摘,2019,19(86):116,128.
[4]
Gawin M, Kurczyk A, Stobiecka E, et al. Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging[J]. Endocr Pathol, 2019, 30(4): 250-261.
[5]
焦飞. 甲状腺患侧腺叶联合峡部切除治疗甲状腺微小乳头状癌近期效果分析[J]. 河南外科学杂志,2019,25(4):99-100.
[6]
Song Y, Fu L-J, Li H-T, et al. Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis[J]. Sci Rep, 2019, 9(1): 5800.
[7]
Varadharajan K, Choudhury N. A systematic review of the incidence of thyroid carcinoma in patients undergoing thyroidectomy for thyrotoxicosis[J]. Clin Otolaryngol, 2020, 45(4): 538-544.
[8]
郑珏如,戴磊,吴贤江,等. 甲状腺患侧叶联合峡部切除术治疗甲状腺微小乳头状癌的近远期疗效[J]. 中华全科医学,2019,17(4):568-570,656.
[9]
Guleria P, Agarwal S, Iyer VK, et al. Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories[J]. J Clin Pathol, 2019, 72(11): 771-777.
[10]
Cheng F, Chen Y, Zhu L, et al. Risk Factors for Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study[J]. Int J Endocrinol, 2019, 2019: 8679828.
[11]
黄亮,李远平,张英毅,等. PTMC患者手术选择及术后甲状腺相关激素水平和并发症比较[J]. 西南国防医药,2019,29(2):185-187.
[12]
Yu F-X, Hu M-X, Zhao H-X, et al. Precise Detection of Gene Mutations in Fine-Needle Aspiration Specimens of the Papillary Thyroid Microcarcinoma Using Next-Generation Sequencing[J]. Int J Endocrinol, 2019, 2019: 4723958.
[13]
康文玉,王翔. 单侧腺叶全切加峡部切除术与双侧腺叶全切除术治疗甲状腺微小乳头状癌的疗效比较[J]. 实用临床医药杂志,2019,23(1):71-74,80.
[14]
Song Y, Fu L-J, Li H-T, et al. Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis[J]. Sci Rep, 2019, 9(1): 5800.
[15]
张伟伟,李向农. 三种术式在甲状腺微小乳头状癌外科治疗中的应用效果比较[J/CD]. 中华普外科手术学杂志(电子版),2017,11(5):397-399.
[16]
Lee S, Bae JS, Jung CK, et al. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties[J]. Cancer Med, 2019, 8(15): 6528-6537.
[17]
Sheng L, Shi J, Han B, et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma[J]. Am J Surg, 2020, 220( 2): 334-340.
[18]
许思哲,贺功建,曾黎,等. 超声联合肿瘤标记物对cN0期甲状腺微小乳头状癌中央区淋巴结隐匿性转移的预测价值[J/CD].中华普通外科手术学杂志(电子版),2021,15(3):314-318.
[1] 汪洪斌, 张红霞, 何文, 杜丽娟, 程令刚, 张雨康, 张萌. 低级别阑尾黏液性肿瘤与阑尾黏液腺癌超声及超声造影特征分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 865-871.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 王伟伟, 费建平, 王璋瑜. 不同手术空间建立方法的经口腔前庭入路腔镜甲状腺术对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 84-87.
[8] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[9] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[11] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[12] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[15] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
阅读次数
全文


摘要